Description: The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.
Exchange: SW
Country: CH : Switzerland
Currency: US Dollar ($)
Category: Sector Equity Biotechnology
| Asset Allocation | |||
|---|---|---|---|
| Asset Class | Long % | Short % | Net Assets |
| Stock US | 87.67 | 0.00 | 87.67 |
| Stock non-US | 12.19 | 0.00 | 12.19 |
| Cash | 0.14 | 0.00 | 0.14 |
| Sector Weights | ||
|---|---|---|
| Sector | Equity % | Relative to Category |
| Healthcare | 100.00 | 99.98 |
| World Regions | ||
|---|---|---|
| Region | Equity % | Relative to Category |
| North America | 88.21 | 84.38 |
| United Kingdom | 5.73 | 3.03 |
| Europe Developed | 4.69 | 9.59 |
| Asia Emerging | 1.12 | 1.79 |
| Asia Developed | 0.25 | 0.51 |
| Japan | 0.00 | 0.58 |
| Australasia | 0.00 | 0.08 |
| Latin America | 0.00 | 0.04 |